Tag: Ludiomil


LUDIOMIL

Ludiomil (Maprotiline): An Atypical Tricyclic Antidepressant Ludiomil, known generically as maprotiline, represents a highly specialized pharmaceutical agent designed primarily for the treatment and management of moderate to severe major depressive disorder (MDD). Although structurally categorized as a tetracyclic antidepressant (TeCA) due to its unique four-ring configuration, it is historically and clinically grouped alongside traditional tricyclic […]

Read More

MAPROTILINE

Maprotiline: A Tetracyclic Antidepressant The Core Definition Maprotiline, often recognized by its former brand name Ludiomil, is classified as an atypical antidepressant that belongs structurally to the group of Tetracyclic Antidepressants (TeCAs). Its primary pharmacological purpose is the clinical treatment of major depressive disorder and various associated mood disturbances. While it shares many functional and […]

Read More